FOLH1 and prostate neoplasm: Prostate-specific membrane antigen (PSMA) is a type II transmembrane glycoprotein (20) (Figure 1) commonly found to be highly expressed in prostate tumor cells, and its levels are about 100–1000 times higher than in normal prostate tissues and other tissues (21, 22).